Zimbabwe has declined a substantial US health deal valued at $367m (272 million pounds) spanning five years because of the United States' demand for confidential data.
This move became public after a government memo dated December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "skewed".
A government spokesperson has since clarified that the United States was seeking biological samples for research and commercial purposes but was unwilling to guarantee the benefits from any future vaccines.
"We will now turn to the difficult and regrettable task of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged further dialogue to reach a agreement agreeable to both sides so the nation's vital HIV programme can continue.
Wider Implications
This rejection follows a comparable situation in neighbouring Kenya, where a court halted a related health funding agreement following legal challenges were raised about the security of Kenyans' health data.
After resuming the presidency last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his government was seeking government-to-government agreements to boost transparency and accountability.
According to reports, Sixteen African countries have so far agreed to these new health pacts, constituting more than $18.3bn in new funding.
Details of the Declined Deal
The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million currently on antiretroviral therapy through American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to provide its biological resources and data indefinitely, without any corresponding guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Put simply, our country would supply the raw materials for scientific discovery without any certainty that the end products would be available to our population should a new pandemic emerge."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the global health body and its push of bilateral deals were disrupting frameworks already set up through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential pandemics.
"This mechanism is intended to guarantee that when a country contributes its samples, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome further discussions with our US partners on how future co-operation might be structured in a way that honours the independence and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that talks need to persist considering much of the country's Aids initiatives depended on foreign aid.
"Where technical issues exist, including those involving information security or implementation frameworks, these can often be resolved via detailed discussion and negotiated safeguards," the group said.
This impasse underscores the continuing tensions between accepting much-needed foreign assistance and safeguarding local interests in an ever more interconnected world.